ENTX Stock Analysis: Buy, Sell, or Hold?
ENTX - Entera Bio Ltd. Ordinary Shares
$2.96
-0.03 (-1.00%)
▼
5d:
-24.49%
30d:
+78.31%
90d:
+169.09%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 14, 2026
9d
Get Alerted When ENTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: ENTX is 8.8% above its trading range ($2.72). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: ENTX is 8.8% above its trading range ($2.72). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: ENTX is currently trading at $2.96, which is considered extended relative to its 30-day fair value range of $1.47 to $2.72.
Technical Outlook: Technically, ENTX is in a uptrend. Immediate support is located at $1.91, while resistance sits at $4.20.
Market Sentiment: ENTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+204.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ENTX is in a uptrend. Immediate support is located at $1.91, while resistance sits at $4.20.
Market Sentiment: ENTX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+204.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.47 -
$2.72
Company Quality Score
61/100
(BUY)
Volume Confirmation
MODERATE
Confidence Score
52.6%
All Signals
- BEARISH: Price extended above range (+8.8% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: Trading 204.1% below Wall St target ($9.00)
- CAUTION: 5-day price weakness (-24.5%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.47 -
$2.72
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.91
Resistance Level
$4.20
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.19
Wall Street Target
$9.00
(+204.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 04, 2026 12:03 AM ET
Data refreshes hourly during market hours. Next update: 1:02 AM
Data refreshes hourly during market hours. Next update: 1:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ENTX showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Geno J Germano
BUY
20000 shares
2026-03-09
Sean Ellis
BUY
10000 shares
2026-03-05
Sean Ellis
BUY
18000 shares
2026-02-09
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$87 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 47 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 51 HOLD |
